Ratings ASMPT Limited OTC Markets

Equities

ASMVY

US00212G1085

Delayed OTC Markets Other stock markets 12:45:39 29/05/2024 am IST			5-day change	1st Jan Change
37.92 ^USD	+5.54%		+6.23%	+32.82%

14/05	ASMPT Limited Appoints Hichem M'saad as Non-Executive Director and Member of the Nomination and Remuneration Committees	CI
08/05	ASMPT Limited Approves Special Dividend for the Year Ended 31 December 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The company's profit outlook over the next few years is a strong asset.
The company is in a robust financial situation considering its net cash and margin position.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

The firm trades with high earnings multiples: 31.47 times its 2024 earnings per share.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Semiconductor Equipment & Testing

	1st Jan change	Capi.	ESG Refinitiv
ASMPT LIMITED	+32.82%	5.15B	-
ASML HOLDING N.V.	+31.44%	377B	B
LAM RESEARCH CORPORATION	+23.38%	127B	B
TOKYO ELECTRON LTD.	+40.57%	105B	B+
ENTEGRIS, INC.	+9.64%	19.95B	C+
ONTO INNOVATION INC.	+50.67%	11.49B	B
SCREEN HOLDINGS CO., LTD.	+26.36%	9.56B	B+
AMKOR TECHNOLOGY, INC.	+0.36%	8.15B	C+
ZHEJIANG JINGSHENG MECHANICAL & ELECTRICAL CO., LTD.	-27.67%	5.85B	D+
CAMTEK LTD.	+55.68%	4.78B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes